Clinical trial
Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer
NCT03433534 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung Cancer
- Lead sponsor
- University Hospital, Tours
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 29, 2018
- Completion date
- December 21, 2018
- Enrollment
- 64 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
kidney cancer, lung cancer